TL;DR: A vaccine designed entirely by artificial intelligence has entered human trials, marking a milestone in AI-driven biotechnology.
Summary: Researchers in the UK have launched a clinical trial for a vaccine designed by AI to target multiple strains of the influenza virus. Developed by the university's AI platform, the vaccine predicts future mutations to offer broader and longer-lasting protection than traditional methods. The trial aims to validate the efficacy of AI-generated antigen designs in humans.
Why it matters: This breakthrough demonstrates the viability of end-to-end AI design in drug discovery, potentially slashing development timelines from years to weeks. AI builders should watch how generative models are increasingly integrated into molecular biology and clinical pipelines.
Source: r/singularity